🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with rapidly progressive ALS will be assigned to IC14 intravenousl...
Status
Withdrawn
Location
Royal Brisbane & Women's Hospital
Start Date
2019-09-01
Trial ID
NCT03474263
Treatments Being Tested
The primary objective is to provide the investigational product, IC14, at t...
Status
No Longer Available
Location
Massachusetts General Hospital
Start Date
TBD
Trial ID
NCT04309604
Treatments Being Tested
Acute Respiratory Distress Syndrome (ARDS) patients will be randomized to r...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06
Trial ID
NCT03017547
Randomized, double-blind, placebo-controlled, safety, PK/PD and preliminary...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-05
Trial ID
NCT03875560
The goal of this clinical trial is to test IC14 (atibuclimab) in patients w...
Status
Completed
Location
Washington University School of Medicine
Start Date
2024-03-29
Trial ID
NCT06275893
Treatments Being Tested
Adults who have had an ST-elevation myocardial infarction and were treated ...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2025-02-06
Trial ID
NCT06678074
Treatments Being Tested
Hospitalized patients with ARDS will be randomized to intravenous treatment...
Status
Recruiting
Location
Harborview Medical Center
Start Date
2026-06-17
Trial ID
NCT06513949
Treatments Being Tested
The goal of this clinical trial is to learn if drug atibuclimab (IC14) work...
Status
Active Not Recruiting
Location
University of Virginia
Start Date
2024-10-17
Trial ID
NCT06556810
Treatments Being Tested
Ten patients with motor neurone disease (MND, also known as amyotrophic lat...
Status
Completed
Location
Royal Brisbane and Women's Hospital
Start Date
2017-10-01
Trial ID
NCT03487263
Treatments Being Tested
This protocol proposes to use IC14, a recombinant chimeric monoclonal antib...
Status
No Longer Available
Location
IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University
Start Date
TBD
Trial ID
NCT04346277
Treatments Being Tested